BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31717692)

  • 21. Mouse apolipoprotein B editing complex 3 (APOBEC3) is expressed in germ cells and interacts with dead-end (DND1).
    Bhattacharya C; Aggarwal S; Kumar M; Ali A; Matin A
    PLoS One; 2008 May; 3(5):e2315. PubMed ID: 18509452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein B messenger RNA editing: an update.
    Chan L
    Biochimie; 1995; 77(1-2):75-8. PubMed ID: 7599279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biologically Aggressive Phenotype and Anti-cancer Immunity Counterbalance in Breast Cancer with High Mutation Rate.
    Takahashi H; Asaoka M; Yan L; Rashid OM; Oshi M; Ishikawa T; Nagahashi M; Takabe K
    Sci Rep; 2020 Feb; 10(1):1852. PubMed ID: 32024876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein B messenger RNA editing: insights into the molecular regulation of post-transcriptional cytidine deamination.
    Davidson NO; Anant S; MacGinnitie AJ
    Curr Opin Lipidol; 1995 Apr; 6(2):70-4. PubMed ID: 7773570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential.
    Butler K; Banday AR
    J Hematol Oncol; 2023 Mar; 16(1):31. PubMed ID: 36978147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular modelling of the biosynthesis of the RNA-editing enzyme APOBEC-1, responsible for generating the alternative forms of apolipoprotein B.
    Scott J; Navaratnam N; Carter C
    Exp Physiol; 1999 Jul; 84(4):791-800. PubMed ID: 10481235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Escherichia coli cytidine deaminase provides a molecular model for ApoB RNA editing and a mechanism for RNA substrate recognition.
    Navaratnam N; Fujino T; Bayliss J; Jarmuz A; How A; Richardson N; Somasekaram A; Bhattacharya S; Carter C; Scott J
    J Mol Biol; 1998 Jan; 275(4):695-714. PubMed ID: 9466941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNA-editing cytidine deaminase Apobec-1 is unable to induce somatic hypermutation in mammalian cells.
    Eto T; Kinoshita K; Yoshikawa K; Muramatsu M; Honjo T
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12895-8. PubMed ID: 14559972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits.
    Hughes SD; Rouy D; Navaratnam N; Scott J; Rubin EM
    Hum Gene Ther; 1996 Jan; 7(1):39-49. PubMed ID: 8825867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunology. RNA editing AIDs antibody diversification?
    Neuberger MS; Scott J
    Science; 2000 Sep; 289(5485):1705-6. PubMed ID: 11001738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNA editing enzyme APOBEC3A promotes pro-inflammatory M1 macrophage polarization.
    Alqassim EY; Sharma S; Khan ANMNH; Emmons TR; Cortes Gomez E; Alahmari A; Singel KL; Mark J; Davidson BA; Robert McGray AJ; Liu Q; Lichty BD; Moysich KB; Wang J; Odunsi K; Segal BH; Baysal BE
    Commun Biol; 2021 Jan; 4(1):102. PubMed ID: 33483601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors.
    Qian X; Balestra ME; Yamanaka S; Borén J; Lee I; Innerarity TL
    Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):1013-20. PubMed ID: 9633945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolutionary analysis of RNA editing enzymes.
    Chang BH; Chan L
    Methods; 1998 May; 15(1):41-50. PubMed ID: 9614651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo.
    Petit V; Guétard D; Renard M; Keriel A; Sitbon M; Wain-Hobson S; Vartanian JP
    J Mol Biol; 2009 Jan; 385(1):65-78. PubMed ID: 18983852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cloning,expression and activity identification of human innate immune protein apolipoprotein B mRNA editing enzyme catalytic subunit 3A(APOBEC3A)].
    Cheng S; Cao L; Du J; Wang W; Guo Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Feb; 33(2):179-84. PubMed ID: 29762985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolutionary origins of apoB mRNA editing: catalysis by a cytidine deaminase that has acquired a novel RNA-binding motif at its active site.
    Navaratnam N; Bhattacharya S; Fujino T; Patel D; Jarmuz AL; Scott J
    Cell; 1995 Apr; 81(2):187-95. PubMed ID: 7736571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22.
    Jarmuz A; Chester A; Bayliss J; Gisbourne J; Dunham I; Scott J; Navaratnam N
    Genomics; 2002 Mar; 79(3):285-96. PubMed ID: 11863358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. APOBEC3-mediated editing in HIV type 1 from pediatric patients and its association with APOBEC3G/CUL5 polymorphisms and Vif variability.
    De Maio FA; Rocco CA; Aulicino PC; Bologna R; Mangano A; Sen L
    AIDS Res Hum Retroviruses; 2012 Jun; 28(6):619-27. PubMed ID: 22145963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct promoters induce APOBEC-1 expression in rat liver and intestine.
    Greeve J; Axelos D; Welker S; Schipper M; Greten H
    Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1079-92. PubMed ID: 9672068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like Gene Expression, RNA Editing, and MicroRNAs Regulation.
    Cao W; Wu W
    Methods Mol Biol; 2018; 1699():75-81. PubMed ID: 29086369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.